Clinical trial

RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID

NCT02316457

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-10-01

PhasePHASE1

Study timeline

Study start (actual)2016-10-01Date precision: month

Registry last updated2026-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer (Triple Negative Breast Cancer (TNBC))unresolved

Interventions

IVAC_W_bre1_uIDBIOLOGICAL

IVAC_W_bre1_uID/IVAC_M_uIDBIOLOGICAL

Sponsors & collaborators

BioNTech SElead sponsor

Seventh Framework Programmecollaborator

Mapped research locations

HeidelbergGermany1 UppsalaSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02316457 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.